[Press release] WHIPPANY, N.J., February 16, 2016 /PRNewswire/ -- Pazoo, Inc., is extremely pleased to announce that the Colorado MED has reached the final stages of the approval process for the transfer of the lab management from the owner Front Range Analytics, LLC to Pazoo licensee Harris Lee Colorado, LLC as of Friday, February 12, 2016, pending final approval of the Marijuana Enforcement Division. The application has been sent to the Licensing office of the MED for the final procedural step of final approval. This change of management will result in several important fundamental developments.
First, Pazoo through its wholly owned subsidiary will immediately transition from a small fee based consulting fee to earning money off of every single test conducted, dramatically increasing revenue generated. Secondly, through all of the aggressive marketing efforts over the last few months, numerous growers, edible producers, CBD and THC oil companies and hemp producers have committed to test with the Harris Lee Colorado lab management team with this transfer.
This Colorado lab was approved for residual solvents testing (RSA) back in December. Being certified for the RSA will open up the market for potential clients, including extraction labs and manufacturers, and will allow the lab to regain former clients who left last year because this crucial certification was not in place. Additionally, the lab has gained several new clients over the months of December and January and is poised for explosive growth.
Pazoo CEO David Cunic stated, “With so many delays in 2015 we are ecstatic to be able to announce to the public that Harris Lee Colorado is about to take over the management of the Denver Colorado testing lab. This means that Pazoo’s revenues in Denver will be lock step with the number of tests to be administered and accordingly we expect to be reporting a big increase in revenue immediately upon final approval. Thank you for all your support and for sticking with us. Everything is finally coming together."
